Polymorphonuclear cells (PMNs) contribute to the initiation and progression
of the immune response by mediating cytotoxicity, phagocytosis, and cytoki
ne secretion. Because CD44 serves as a cytotoxic-triggering molecule on PMN
s, it was hypothesized that it could also trigger cytokine production, In t
his study, the effect of anti-CD44 antibodies on interleukin-6 (IL-6) produ
ction in human PMNs was assessed, By using a reverse transcriptase-polymera
se chain reaction, it was shown that PMNs stimulated with a mouse monoclona
l or a rabbit polyclonal F(ab)(2) anti-CD44 transcribe IL-6 messenger RNA.
A similar effect was obtained when an anti-CD44 antibody was replaced with
hyaluronic acid (HA), Kinetic studies showed that anti CD44 and HA induced
IL-6 gene transcription, initiated 3 hours after stimulation, peaked betwee
n 12 and 24 hours, and disappeared after 48 hours. Analogous results were a
chieved when secreted IL-6 protein was measured by enzyme-linked immunosorb
ent assay in the PMN culture supernatants, To characterize which metabolic
pathways regulated CD44-dependent IL-6 production in PMNs, an RNA polymeras
e inhibitor, actinomycin D, and 2 protein kinase inhibitors, such as genist
ein and staurosporine, were tested. Actinomycin D and genistein blocked IL-
6 production, whereas staurosporine did not, suggesting that CD44-dependent
IL-6 production requires gene transcription and tyrosine kinase activity.
Furthermore, the relationship between CD44 and cytokines that affect PMN fu
nction, including interferon gamma (IFN gamma) and IL-2, was investigated.
Without CD44 cross-linking, IFN gamma did not trigger IL-6 production. Howe
ver, on CD44 cross-linking, IFN gamma produced a strong synergistic effect
on IL-6 syntheses in human PMNs.